Publications by authors named "Daniel Hertz"

Claim this Profile
A
Association of Genetic Variation in CES, UGT, ABC, and SLCO with Irinotecan Infusion Reactions and Severe Toxicity: Corrigendum.
Kelly I Nugent, Lyucheng Huang, Maisa Nazzal, Amy L Pasternak, Daniel L Hertz

Pharmacogenet Genomics· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of SULT2A1 Locus With Abiraterone Clearance in the Alliance A031201: Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer.
Nadine Norton, Nicholas B Larson, Gregory D Jenkins, Jan H Beumer, Brooke Langevin, Daniel L Hertz

Clin Transl Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging implementation science to enhance the adoption of DPYD testing.
Sony Tuteja, J Kevin Hicks, Larisa H Cavallari, Nihal El Rouby, D Max Smith, Daniel L Hertz

Pharmacogenet Genomics· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic-Pharmacodynamic Model of Paclitaxel-Induced Peripheral Neuropathy.
Yuchen Sun, Manjunath P Pai, N Lynn Henry, Daniel L Hertz

Clin Transl Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges.
D Max Smith, Michael P Douglas, Christina L Aquilante, Patricia A Deverka, Beth Devine, Daniel L Hertz

Clin Pharmacol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of genetic variation with irinotecan infusion reactions and severe toxicity.
Kelly I Nugent, Lyucheng Huang, Maisa Nazzal, Amy L Pasternak, Daniel L Hertz

Pharmacogenet Genomics· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic association of CYP enzymes with therapeutic propofol doses during mechanical ventilation.
Chanel Hsiang, Faisal Shakeel, Nicholas Farina, Ken Johnson, Daniel L Hertz

Pharmacogenet Genomics· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of the contribution of clinical and genetic factors to the racial disparity in taxane-induced peripheral neuropathy.
Nam Nguyen-Hoang, Maisa Nazzal, Bryan P Schneider, Meghna S Trivedi, Daniel L Hertz

Crit Rev Oncol Hematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding biobank pharmacogenomics through machine learning calls of structural variation.
Brett Vanderwerff, Amy L Pasternak, Lars G Fritsche, Emily Bertucci-Richter, Snehal Patil, Daniel L Hertz

Genetics· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerance for chemotherapy-induced peripheral neuropathy among women with metastatic breast cancer: a discrete-choice experiment.
Rotana M Radwan, Anne L R Schuster, Daniel L Hertz, Maryam B Lustberg, Hetal R Vachhani

Breast Cancer Res Treat· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing Fluorouracil Doses in Patients With Partial Dihydropyrimidine Dehydrogenase Deficiency Is a Treatment Safety Strategy, Not a Panacea of Precision Dosing.
Daniel L Hertz, Alan P Venook

JCO Precis Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice.
Teresa T Ho, D Max Smith, Christina L Aquilante, Emily J Cicali, Nihal El Rouby, Daniel L Hertz

Clin Pharmacol Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors influencing the decision to discontinue treatment due to chemotherapy-induced peripheral neuropathy among patients with metastatic breast cancer: a best-worst scaling.
Rotana M Radwan, John F P Bridges, Daniel L Hertz, Maryam B Lustberg, Hetal Vachhani

Support Care Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixed-methods Study of the Effect of Chemotherapy-induced Peripheral Neuropathy SymptomPermanence on Patient's Willingness to Alter Neurotoxic Chemotherapy Treatment.
Yerial Jun, Xueting Tao, Jaeyoung Choi, Kelley M Kidwell, Daniel L Hertz

Res Sq· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic associations of GATA4 and KCNQ1 with ibrutinib cardiovascular toxicity.
Kelly I Nugent, Lyucheng Huang, Jai N Patel, Daniel L Hertz

Pharmacogenet Genomics· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported strategies for prevention and treatment of chemotherapy-induced peripheral neuropathy.
Daniel L Hertz, Mary Tanay, Cindy Tofthagen, Emanuela Rossi, Davide Paolo Bernasconi

Support Care Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remote Monitoring of Chemotherapy-Induced Peripheral Neuropathy by the NeuroDetect iOS App: Observational Cohort Study of Patients With Cancer.
Ciao-Sin Chen, Michael P Dorsch, Sarah Alsomairy, Jennifer J Griggs, Reshma Jagsi, Daniel L Hertz

J Med Internet Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Eccentricity Gradient Reversal across High-Level Visual Cortex.
Edan Daniel-Hertz, Jewelia K Yao, Sidney Gregorek, Patricia M Hoyos, Jesse Gomez

J Neurosci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitation of Plasma Proteins to Predict Taxane-Induced Peripheral Neuropathy.
Nam Nguyen-Hoang, Yaping Liu, N Lynn Henry, Manjunath P Pai, Hao-Jie Zhu, Daniel L Hertz

JCO Precis Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care-an international Delphi study.
Raymond Javan Chan, Reegan Knowles, Fredrick D Ashbury, Joanne Bowen, Alexandre Chan, Daniel L Hertz

EClinicalMedicine· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential association of and variant alleles with increased risk for palbociclib toxicity.
Chong Wang, Mary Hwang, Brandon Paulson, Doreen Mhandire, Sadat Ozair, Daniel L Hertz

Pharmacogenomics· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for pharmacogenetic testing in clinical practice guidelines in the US.
Daniel L Hertz, Chad A Bousman, Howard L McLeod, Andrew A Monte, Deepak Voora

Am J Health Syst Pharm· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221.
Ciao-Sin Chen, Gary Zirpoli, G Thomas Budd, William E Barlow, Lajos Pusztai, Daniel L Hertz

Cancer Chemother Pharmacol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for DPYD testing prior to fluoropyrimidine chemotherapy in the US.
Tabea Tracksdorf, D Max Smith, Skyler Pearse, Emily J Cicali, Christina L Aquilante, Daniel L Hertz

Support Care Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using maximum plasma concentration (C) to personalize taxane treatment and reduce toxicity.
Yuchen Sun, Yue Cheng, Daniel L Hertz

Cancer Chemother Pharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis